{"result": "(\"entity\"<|>ENFERMEDADES HEPÁTICAS Y DIGESTIVAS<|>ORGANIZATION<|>CIBERehd is a CIBER focused on liver and digestive diseases, aiming to advance research in these health areas.)\n##\n(\"entity\"<|>ENFERMEDADES RARAS<|>ORGANIZATION<|>CIBERer is a CIBER dedicated to rare diseases, promoting research and understanding of these conditions.)\n##\n(\"entity\"<|>EPIDEMIOLOGÍA Y SALUD PÚBLICA<|>ORGANIZATION<|>CIBEResp is a CIBER that focuses on epidemiology and public health research.)\n##\n(\"entity\"<|>BIOINGENIERÍA, BIOMATERIALES Y NANOMEDICINA<|>ORGANIZATION<|>CIBERbbn is a CIBER that specializes in bioengineering, biomaterials, and nanomedicine research.)\n##\n(\"entity\"<|>DIABETES Y ENFERMEDADES METABÓLICAS<|>ORGANIZATION<|>CIBERdem is a CIBER focused on diabetes and metabolic diseases research.)\n##\n(\"entity\"<|>ENFERMEDADES NEURODEGENERATIVAS<|>ORGANIZATION<|>CIBERned is a CIBER dedicated to research on neurodegenerative diseases.)\n##\n(\"entity\"<|>FISIOPATOLOGÍA DE LA OBESIDAD Y LA NUTRICIÓN<|>ORGANIZATION<|>CIBERobn is a CIBER that studies the pathophysiology of obesity and nutrition.)\n##\n(\"entity\"<|>SALUD MENTAL<|>ORGANIZATION<|>CIBERsam is a CIBER focused on mental health research.)\n##\n(\"entity\"<|>ENFERMEDADES RESPIRATORIAS<|>ORGANIZATION<|>CIBERes is a CIBER that specializes in respiratory diseases research.)\n##\n(\"relationship\"<|>CIBEROBN<|>CIBER<|>CIBERobn is part of the CIBER network, focusing specifically on obesity and nutrition<|>8)\n##\n(\"relationship\"<|>CIBER<|>ENFERMEDADES HEPÁTICAS Y DIGESTIVAS<|>CIBER includes various specific CIBERs like CIBERehd that focus on liver and digestive diseases<|>6)\n##\n(\"relationship\"<|>CIBER<|>ENFERMEDADES RARAS<|>CIBER includes various specific CIBERs like CIBERer that focus on rare diseases<|>6)\n##\n(\"relationship\"<|>CIBER<|>EPIDEMIOLOGÍA Y SALUD PÚBLICA<|>CIBER includes various specific CIBERs like CIBEResp that focus on epidemiology and public health<|>6)\n##\n(\"relationship\"<|>CIBER<|>BIOINGENIERÍA, BIOMATERIALES Y NANOMEDICINA<|>CIBER includes various specific CIBERs like CIBERbbn that focus on bioengineering and nanomedicine<|>6)\n##\n(\"relationship\"<|>CIBER<|>DIABETES Y ENFERMEDADES METABÓLICAS<|>CIBER includes various specific CIBERs like CIBERdem that focus on diabetes and metabolic diseases<|>6)\n##\n(\"relationship\"<|>CIBER<|>ENFERMEDADES NEURODEGENERATIVAS<|>CIBER includes various specific CIBERs like CIBERned that focus on neurodegenerative diseases<|>6)\n##\n(\"relationship\"<|>CIBER<|>FISIOPATOLOGÍA DE LA OBESIDAD Y LA NUTRICIÓN<|>CIBER includes various specific CIBERs like CIBERobn that focus on obesity and nutrition<|>6)\n##\n(\"relationship\"<|>CIBER<|>SALUD MENTAL<|>CIBER includes various specific CIBERs like CIBERsam that focus on mental health<|>6)\n##\n(\"relationship\"<|>CIBER<|>ENFERMEDADES RESPIRATORIAS<|>CIBER includes various specific CIBERs like CIBERes that focus on respiratory diseases<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: medicamentos de uso humano, el Ane-\nxo VI de la Circular 15/2002 de la Agencia Española del\nMedicamento (AEM) y la legislación específica de cada\n---\n# BLOQUE: NUTRICIÓN Y ASPECTOS LEGALES\n\ncomunidad autónoma. A diferencia de los ensayos clínicos, la legislación de los estudios observacionales es menos estricta, diferenciándose principalmente en los siguientes puntos: exención de la obligatoriedad del seguro, no exigencia del informe del Comité Ético de Investigación Clínica si se emplean registros preexistentes que no contengan datos de carácter personal, en algunos casos puede ser obviado el consentimiento informado del paciente, el estudio no debe interferir en la actividad asistencial, ni alterar la prescripción del investigador.\n\nEn temas de nutrición oral o enteral, no existe una legislación que regule el desarrollo de proyectos de investigación. Los productos dietoterápicos no son fármacos, y se definen como «alimentos destinados a usos médicos especiales» y están incorporados en el Registro General Sanitario de Alimentos. Aun así, son numerosos los centros o institutos de investigación, hospitales, fundaciones sanitarias o universidades, que exigen a sus profesionales la aprobación por el comité de ética de todos los estudios sobre nutrición oral, enteral o de alimentación que realicen.\n\n## 5. Organización de los grupos de investigación en España\n\n### 5.1. CIBER\n\nLos Centros de Investigación Biomédica en Red (CIBER) son Estructuras Estables de Investigación Cooperativa, incluidas en la Línea de Articulación del Sistema de la Acción Estratégica de Salud.\n\nEntre los objetivos del Programa Ingenio 2010, dentro del «Programa Consolider», para incrementar la masa crítica y la excelencia investigadora, figura la creación de Centros de Investigación Biomédica en Red (CIBER) mediante la constitución de consorcios. Estos consorcios cuentan con personalidad jurídica propia, sin contigüidad física, tienen como objetivo la investigación monográfica sobre una patología o problema de salud determinado, definido de una forma amplia. Los CIBER se forman a través de la asociación de grupos de investigación, vinculables al Sistema Nacional de Salud, para contribuir a fundamentar científicamente los programas y políticas del Sistema Nacional de Salud en las áreas prioritarias del Plan Nacional de I+D+I.\n\nEl propósito de la creación y el mantenimiento de los CIBER es impulsar la investigación de excelencia en biomedicina y ciencias de la salud, que se realiza en el Sistema Nacional de Salud y en el Sistema de Ciencia y Tecnología. La importancia de este objetivo para la ciencia, la salud y la sociedad en general hace necesario que el ISCIII asuma la promoción y apoye la financiación de estos CIBER.\n\nEn la actualidad, existen nueve CIBER: Enfermedades hepáticas y digestivas (CIBERehd), Enfermedades raras (CIBERer), Epidemiología y salud pública (CIBEResp), Bioingeniería, biomateriales y nanomedicina (CIBERbbn), Diabetes y enfermedades metabólicas (CIBERdem), Enfermedades neurodegenerativas (CIBERned), Fisiopatología de la obesidad y la nutrición (CIBERobn), Salud mental (CIBERsam) y Enfermedades respiratorias (CIBERes).\n\nA nivel nutricional, el CIBERobn tiene como misión principal ayudar en el avance del entendimiento de los mecanismos que contribuyen al desarrollo de la obesidad para reducir su incidencia y prevalencia, así como sus complicaciones, además de las enfermedades relacionadas con la nutrición. A través de su liderazgo en la investigación biomédica traslacional, integra la investigación básica, clínica, epidemiológica y de salud pública, así como la asistencia médica y la educación en el ámbito público de la obesidad y la nutrición, convirtiéndose por todo ello en un centro de investigación de referencia con un potencial competitivo de internacionalización y para proveer servicios de asesoría en I+D+I a compañías tanto farmacéuticas como de la alimentación, así como a las autoridades sanitarias del país. El CIBERobn es una estructura cooperativa en red, formada por 31 grupos ubicados en algunos de los principales centros de investigación de España. Estos grupos se estructuran en seis Programas de Investigación donde se desarrollan proyectos que permiten, a través de un trabajo multidisciplinar, sumar esfuerzos, optimizar recursos y aprovechar al máximo el conocimiento generado para poder transferirlo a la práctica clínica y, en última instancia, ofrecerlo al servicio del paciente y del conjunto de la sociedad.\n\n### 5.2. RETICS\n\nLas Redes temáticas de investigación cooperativa en salud (RETICS) son estructuras organizativas formadas por la asociación al Instituto de Salud Carlos III de un conjunto variable de centros y grupos\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>AGENCIA ESPAÑOLA DEL MEDICAMENTO<|>ORGANIZATION<|>The Agencia Española del Medicamento is a regulatory body responsible for the evaluation and supervision of medicines and medical devices in Spain.)\n##\n(\"entity\"<|>CIBER<|>ORGANIZATION<|>CIBER (Centros de Investigación Biomédica en Red) are cooperative research structures aimed at promoting biomedical research in Spain, focusing on specific health issues.)\n##\n(\"entity\"<|>ISCIII<|>ORGANIZATION<|>The Instituto de Salud Carlos III (ISCIII) is a public research institution in Spain that promotes and finances health research.)\n##\n(\"entity\"<|>CIBEROBN<|>ORGANIZATION<|>CIBERobn is a specific CIBER focused on obesity and nutrition research, aiming to understand mechanisms contributing to obesity and related health issues.)\n##\n(\"entity\"<|>RETICS<|>ORGANIZATION<|>RETICS (Redes temáticas de investigación cooperativa en salud) are thematic networks formed to enhance cooperative health research in Spain.)\n##\n(\"relationship\"<|>CIBER<|>ISCIII<|>CIBER is associated with the ISCIII for the purpose of promoting and financing biomedical research in Spain<|>7)\n##\n(\"relationship\"<|>CIBEROBN<|>CIBER<|>CIBERobn is a specific initiative under the CIBER umbrella, focusing on obesity and nutrition<|>8)\n##\n(\"relationship\"<|>AGENCIA ESPAÑOLA DEL MEDICAMENTO<|>CIBER<|>The Agencia Española del Medicamento regulates the research and development of medicines, which is relevant to the research conducted by CIBER<|>5)\n##\n(\"relationship\"<|>RETICS<|>ISCIII<|>RETICS are organized under the auspices of the ISCIII to enhance health research collaboration<|>6)\n<|COMPLETE|>"}]}